Ken Stratton
General Counsel at PULSE BIOSCIENCES, INC.
Profile
Kenneth B.
Stratton is currently the Secretary & General Counsel at Pulse Biosciences, Inc. He was previously the President, Secretary & General Counsel at StemCells, Inc. from 2016 to 2021.
Prior to that, he was the Senior Legal Counsel-Vascular Business Unit at Medtronic, Inc. from 2004 to 2006 and the Deputy General Counsel at Threshold Pharmaceuticals, Inc. from 2006 to 2007.
He was also a Partner at Rogoway Law Group, A PC.
Mr. Stratton received his undergraduate degree from the University of Pennsylvania, his MBA from The Leonard N Stern School of Business, and his graduate degree from New York University School of Law.
Ken Stratton active positions
| Companies | Position | Start |
|---|---|---|
| PULSE BIOSCIENCES, INC. | General Counsel | 2021-04-30 |
Former positions of Ken Stratton
| Companies | Position | End |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | President | 2021-04-30 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | 2007-01-31 |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | 2006-06-30 |
Rogoway Law Group, A PC
 Rogoway Law Group, A PC Miscellaneous Commercial ServicesCommercial Services Rogoway Law Group, A PC provides legal services for the cannabis and hemp industries. The private company is based in Santa Rosa. | Corporate Officer/Principal | - |
Training of Ken Stratton
| University of Pennsylvania | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
| New York University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PULSE BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
Rogoway Law Group, A PC
Rogoway Law Group, A PC Miscellaneous Commercial ServicesCommercial Services Rogoway Law Group, A PC provides legal services for the cannabis and hemp industries. The private company is based in Santa Rosa. | Commercial Services |
- Stock Market
- Insiders
- Ken Stratton